[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
Calvin Sternick Maintained (UHS) at Hold with Decreased Target to $144 on, Nov 17th, 2023
- 🞛 This publication is a summary or evaluation of another publication
Calvin Sternick of JP Morgan, Maintained "Universal Health Services, Inc." (UHS) at Hold with Decreased Target from $152 to $144 on, Nov 17th, 2023.
Calvin has made no other calls on UHS in the last 4 months.
There are 6 other peers that have a rating on UHS. Out of the 6 peers that are also analyzing UHS, 3 agree with Calvin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Stephen Baxter of "Wells Fargo" Maintained at Hold with Decreased Target to $139 on, Friday, October 20th, 2023
- Steven Valiquette of "Barclays" Maintained at Hold and Held Target at $142 on, Thursday, September 21st, 2023
- Scott Fidel of "Stephens & Co." Reiterated at Hold and Held Target at $155 on, Wednesday, July 26th, 2023
These are the ratings of the 3 analyists that currently disagree with Calvin
- Sarah James of "Cantor Fitzgerald" Reiterated at Sell and Held Target at $148 on, Thursday, September 14th, 2023
- Jonathan Yon of "Credit Suisse" Maintained at Buy with Increased Target to $169 on, Thursday, July 27th, 2023
- Kevin Fischbeck of "B of A Securities" Maintained at Strong Buy and Held Target at $183 on, Thursday, July 27th, 2023